ITGAX and obesity disorder: The transient anti-obesity effect was suggested to be exerted by temporarily suppressing the recruitment or differentiation of CD11c + M2 macrophages in adipose tissue and reducing production of growth/ differentiation factor 3, which inhibits lipolysis of adipose tissue and accelerates obesity39.